Catalogue of self-targeting nano-medical inventions to accelerate clinical trials
Literature Information
Samar A. Alsudir
Repetitive outbreaks and prolonged epidemics represent mortal threats to global health, creating chaos in our globalized world. To date, scientists have been compelled to follow FDA guidelines for conventional clinical trials, which decelerates the release of effective therapies to battle outbreaks and safeguard global health security. Developing multi-purpose platform nanotechnologies to self-target specific organs in response to the disease microenvironment could greatly help to rapidly anticipate and efficiently manage outbreaks. Nano-interventions in the form of self-targeting nanoparticles (NPs) could accelerate the clinical translation of potential drugs to fight future outbreaks via innovating their clinical trials. This review sets the foundation of the self-targeting concept to govern the in vivo fate of NPs without the need to complicate the engineering designs with targeting ligands. The proposed catalogue of accelerated nano-innovations offers self-targeting, physiological trafficking, bio-compliance, and controllable drug release in response to associated smart linkers.
Related Literature
IF 6.367
Carbon-based photocatalysts for enhanced photocatalytic reduction of CO2 to solar fuelsIF 6.367
Ether-functionalization of monoethanolamine (MEA) for reversible CO2 capture under solvent-free conditions with high-capacity and low-viscosityIF 6.367
Non-aqueous neptunium and plutonium redox behaviour in THF – access to a rare Np(iii) synthetic precursorIF 6.222
Carbon and carbon composites obtained using deep eutectic solvents and aqueous dilutions thereofIF 6.222
Developing a novel high performance NaNbO3-based lead-free dielectric capacitor for energy storage applicationsIF 6.367
A model-based comparison of Ru and Ni catalysts for the Sabatier reactionIF 6.367
Catalogue of self-targeting nano-medical inventions to accelerate clinical trialsIF 6.843
Milk exosomes with enhanced mucus penetrability for oral delivery of siRNAIF 6.843
Building microsphere–nanosheet structures in N-doped carbon to improve its performance in the oxygen reduction reaction and vanadium redox flow batteriesIF 6.367
Source Journal
Biomaterials Science

Biomaterials Science is an international high impact journal exploring the science of biomaterials and their translation towards clinical use. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions. Papers do not necessarily need to report a new biomaterial but should provide novel insight into the biological applications of the biomaterial. Articles that primarily focus on demonstrating novel materials chemistry and bring a molecular picture to bear on a given material’s suitability as a biomaterial are more suited to our companion journal, Journal of Materials Chemistry B. Biomaterials Science publishes primary research and review-type articles in the following areas: molecular design of biomaterials, including translation of emerging chemistries to biomaterials science of cells and materials at the nanoscale and microscale materials as model systems for stem cell and human biology materials for tissue engineering and regenerative medicine (Nano)materials and (nano)systems for therapeutic delivery interactions at the biointerface biologically inspired and biomimetic materials, including bio-inspired self-assembly systems and cell-inspired synthetic tools next-generation biomaterials tools and methods